
LP30 : Liver-directed allosteric inhibitors of acetyl-coa carboxylase favorably impact pathophysiology in the progression from nafld to nash and hepatocellular carcinoma, including hepatic steatosis, inflammation, and fibrosis
Westlin, W.F., Harwood, H.J., DePeralta, D.K., Moaven, O., Wei, L., Greenwood, J., Bhat, S., Fuchs, B.C., Kapeller, R., Harriman, G.Volume:
62
Langue:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30184-7
Date:
April, 2015
Fichier:
PDF, 41 KB
english, 2015